These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33450841)

  • 21. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
    James RW; Deakin SP
    Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.
    Marsillach J; Aragonès G; Mackness B; Mackness M; Rull A; Beltrán-Debón R; Pedro-Botet J; Alonso-Villaverde C; Joven J; Camps J
    Lipids Health Dis; 2010 May; 9():46. PubMed ID: 20470383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human carotid plaque phosphatidylcholine specifically interacts with paraoxonase 1, increases its activity, and enhances its uptake by macrophage at the expense of its binding to HDL.
    Cohen E; Aviram M; Khatib S; Artoul F; Rabin A; Mannheim D; Karmeli R; Salamon T; Vaya J
    Free Radic Biol Med; 2014 Nov; 76():14-24. PubMed ID: 25091896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Di-oleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies.
    Efrat M; Rosenblat M; Mahmood S; Vaya J; Aviram M
    Atherosclerosis; 2009 Feb; 202(2):461-9. PubMed ID: 18585720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
    Nus M; Frances F; Librelotto J; Canales A; Corella D; Sánchez-Montero JM; Sánchez-Muniz FJ
    J Nutr; 2007 Jul; 137(7):1783-8. PubMed ID: 17585031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
    Liu ML; James RW; Ylitalo K; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lipoic acid on paraoxonase-1 and paraoxonase-3 protein levels, mRNA expression and arylesterase activity in liver hepatoma cells.
    Ozgun E; Sayilan Ozgun G; Tabakcioglu K; Suer Gokmen S; Sut N; Eskiocak S
    Gen Physiol Biophys; 2017 Oct; 36(4):465-470. PubMed ID: 28653653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
    Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
    Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens.
    Kim K; Bloom MS; Fujimoto VY; Browne RW
    PLoS One; 2017; 12(2):e0172193. PubMed ID: 28196109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.
    Meisinger C; Freuer D; Bub A; Linseisen J
    Lipids Health Dis; 2021 Jul; 20(1):81. PubMed ID: 34332593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The paraoxonase 1, 2 and 3 in humans.
    Rajkovic MG; Rumora L; Barisic K
    Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
    Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
    Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postprandial Paraoxonase 1 Activity Following Consumption of Recommended Amounts of Mixed Meals in Healthy Males.
    Kameyama N; Maruyama C; Kotani K; Caccavello R; Gugliucci A; Matsui S; Araki R; Maruyama T
    J Atheroscler Thromb; 2016; 23(2):225-32. PubMed ID: 26447089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
    Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
    Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
    Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
    J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor.
    Moreno-Godínez ME; Galarce-Sosa C; Cahua-Pablo JÁ; Rojas-García AE; Huerta-Beristain G; Alarcón-Romero LDC; Cruz M; Valladares-Salgado A; Antonio-Véjar V; Ramírez-Vargas MA; Flores-Alfaro E
    Arch Med Res; 2018 Oct; 49(7):486-496. PubMed ID: 30853125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
    Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
    Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.